Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UV-stimulated scaffold protein A (UVSSA) is a human DNA repair protein critical for the transcription-coupled nucleotide excision repair (TC-NER) pathway, which specifically addresses UV-induced DNA lesions blocking RNA polymerase II during transcription[3][1][4][5][6][7]. UVSSA stabilizes Cockayne syndrome B protein (CSB) by recruiting the deubiquitinating enzyme USP7 to repair complexes and prevents degradation of repair proteins by the proteasome[1][3][5]. Loss-of-function mutations in the UVSSA gene cause UV-sensitive syndrome, a rare autosomal recessive disorder characterized by hypersensitivity to UV light and deficiency in repair of transcription-blocking DNA damage[3][5]. This protein is essential for clearing RNA polymerase II-blocking lesions, and its absence leads to impaired DNA repair and aberrant recovery of transcription after UV irradiation[5][3]. UVSSA does not have known direct small molecule modulators or recognized use as a classical therapeutic target, such as a receptor, transporter, or enzyme[3][7][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UV-stimulated scaffold protein A (UVSSA).